2434-56-2

Usage

Uses

Used in Pharmaceutical Industry:
4,6-Diaminopyrimidine is used as a precursor compound for the synthesis of various pharmaceutical goods. Its importance lies in its ability to be transformed into organotin polyamines through a reaction process. These organotin polyamines have demonstrated effective inhibition against two pancreatic cancer cell lines, showcasing their potential as therapeutic agents in the fight against cancer.
Additionally, 4,6-Diaminopyrimidine's role in the pharmaceutical industry extends beyond cancer treatment, as it can be utilized in the development of other medicinal compounds with diverse applications. Its versatility as a building block for pharmaceutical products makes it a valuable asset in the field of drug discovery and development.

InChI:InChI=1/C4H6N4/c5-3-1-4(6)8-2-7-3/h1-2H,(H4,5,6,7,8)

Upstream product

• 333-49-3 2-thiocytosine 
• 1073-99-0 4,5,6-triamino-2-mercapto-pyrimidine 

Downstream Products

• 103261-00-3 5-(4-chloro-phenylazo)-pyrimidine-4,6-diyldiamine 
• 30162-02-8 2,7-diaminothiazolo<4,5-d>pyrimidine 
• 89533-23-3 N-(6-aminopyrimidin-4-yl)acetamide 
• 58023-98-6 5-bromo-4,6-diaminopyrimidine 
• 2164-84-3 4,6-Diamino-5-nitropyrimidine 
• 102712-36-7 4-(4,6-Diamino-pyrimidin-5-ylazo)-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide 
• 128926-49-8 C₁₀H₉BrN₅⁽¹⁵⁾N 
• 214907-09-2 4,6-diamino-5-iodopyrimidine 
• 908084-16-2 2-phenylimidazo[1,2-c]pyrimidin-7-ylamine 
• 1229383-37-2 imidazo[1,2-c]pyrimidin-7-ylamine 
• 1334409-77-6 N₄-(2-(2,6-dichlorophenyl)-3H-imidazo[4,5-c]pyridin-4-yl)pyrimidine-4,6-diamine 
• 1334410-01-3 4-(4-(6-aminopyrimidin-4-ylamino)-3H-imidazo[4,5-c]pyridin-2-yl)-3,5-dichlorobenzonitrile 
• 1193-21-1 4,6-dichloropyrimidine 

Relevant academic research and scientific papers

Cephalosporin antibiotics

The present invention relates to a cephalosporin compound represented by the following general formula (I): STR1 its pharmaceutically acceptable non-toxic salt, physiologically hydrolyzable ester, hydrate or solvate, or isomers thereof, in whichR 1 represents hydrogen or an amino-protecting group,R 2 and R 3 can be identical or different and independently of one another represent hydrogen or a hydroxy-protecting group, orR 2 and R 3 together can form a cyclic diol-protecting group,R 4 represents hydrogen or a carboxyl-protecting group,R 5, R 6 and R 7 independently of one another represent hydrogen, amino or substituted amino, hydroxy, alkoxy, C 1-4 alkyl, carboxyl or alkoxycarbonyl, orR 5 and R 6 together with the carbon atoms to which they are attached can form a C 3-7 cycle, andQ represents CH or N,and to a process for preparation thereof and a pharmaceutical composition containing the compound (I) as an active ingredient.